Stay updated on BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial
Sign up to get notified when there's something new on the BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial page.

Latest updates to the BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial page
- ChecktodayChange DetectedThe new screenshot shows only minor UI refinements and formatting updates (e.g., minor layout tweaks and an updated last updated timestamp) without changes to the study title, eligibility criteria, primary or secondary outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now includes a government-funding and operating-status notice and marks a new version (v3.2.0), replacing the previous v3.1.0.SummaryDifference4%

- Check29 days agoChange DetectedThe page now adds a new version tag (v3.1.0) and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision (v3.0.2). This indicates a content scope change rather than a simple update.SummaryDifference0.4%

- Check43 days agoChange DetectedMinor version bump from v3.0.1 to v3.0.2; no core content, pricing, stock, or time-slot data appears updated. The deletions include the old revision tag and a Back to Top control, which is a minor UI change.SummaryDifference0.2%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has been updated to include a new facility name and location in Washington D.C., along with significant additions related to drug safety and various biological factors, while removing several specific drug names and related medical terms.SummaryDifference5%

Stay in the know with updates to BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial page.